Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Santen Pharmaceutical CO Ltd (SNPHF)

Santen Pharmaceutical CO Ltd (SNPHF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.21
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.5200 unch
on 07/30/19
16.5200 unch
on 07/30/19
N/A (+9.04%)
since 05/02/19
3-Month
15.1500 +9.04%
on 05/02/19
16.5200 unch
on 07/30/19
+1.6700 (+11.25%)
since 04/29/19
52-Week
14.7000 +12.38%
on 10/31/18
16.5200 unch
on 07/30/19
-0.4300 (-2.54%)
since 06/28/18

Most Recent Stories

More News
TRACON Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration...

SNPHF : 16.5200 (+9.04%)
TCON : 0.52 (unch)
TRACON Pharmaceuticals to Participate in the 2019 BTIG Biotechnology Conference

TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration...

SNPHF : 16.5200 (+9.04%)
TCON : 0.52 (unch)
Meiji Seika Pharma to Launch Two Products from Santen Pharmaceutical Co., Ltd. in Indonesia

Meiji Seika Pharma Co., Ltd. "Meiji" has announced that it launched the following two products from Santen Pharmaceutical Co., Ltd. "Santen" in Indonesia, based on a working business agreement that Meiji...

SNPHF : 16.5200 (+9.04%)
TRACON to Report Second Quarter 2019 Company Highlights and Financial Results on August 7, 2019

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration...

SNPHF : 16.5200 (+9.04%)
TCON : 0.52 (unch)
TRACON Pharmaceuticals to Participate in Wells Fargo Securities 2019 Biotech Corporate Access Day

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration...

SNPHF : 16.5200 (+9.04%)
WFC : 44.42 (-2.63%)
TCON : 0.52 (unch)
TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and through our license to Santen...

SNPHF : 16.5200 (+9.04%)
TCON : 0.52 (unch)
TRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and, through our license to Santen...

SNPHF : 16.5200 (+9.04%)
TCON : 0.52 (unch)
Santen and Glaukos Enter into Collaboration and Distribution Agreement for Exclusive Distribution of the MicroShunt (DE-128) in the United States

Santen Pharmaceutical Co., Ltd. ("Santen" TSE: 4536) and Glaukos Corporation ("Glaukos" NYSE: GKOS), announced today that Santen's U.S. subsidiary, Santen Inc., has entered into a multi-year...

SNPHF : 16.5200 (+9.04%)
GKOS : 58.58 (-4.22%)
TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and, through our license to Santen...

SNPHF : 16.5200 (+9.04%)
TCON : 0.52 (unch)
TRACON Pharmaceuticals Announces TRC105, TRC253 and TRC102 Data Presentations at Upcoming AACR Annual Meeting

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and, through our license to Santen...

SNPHF : 16.5200 (+9.04%)
TCON : 0.52 (unch)
Trade SNPHF with:

Key Turning Points

2nd Resistance Point 16.5200
1st Resistance Point 16.5200
Last Price 16.5200
1st Support Level 16.5200
2nd Support Level 16.5200

See More

52-Week High 16.5200
Last Price 16.5200
Fibonacci 61.8% 15.8248
Fibonacci 50% 15.6100
Fibonacci 38.2% 15.3952
52-Week Low 14.7000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar